Zobrazeno 1 - 8
of 8
pro vyhledávání: '"Evelien W.M. Kemna"'
Autor:
Claire Matthews, Stephen MacDonald, Martin Besser, Florian Falter, José Cañameres, Evelien W.M. Kemna
Publikováno v:
Journal of Cardiothoracic and Vascular Anesthesia. 34:2921-2927
The activated clotting time (ACT) is used worldwide to confirm safe heparin anticoagulation for cardiopulmonary bypass. For the present study, the performances of 2 commonly used ACT devices were compared with each other and with anti-Xa levels throu
Autor:
Jos A H van Oers, Albertus Beishuizen, Johannes G. Krabbe, Dylan W. de Lange, Yvette Kluiters, Armand R. J. Girbes, Evelien W.M. Kemna, P Vos
Publikováno v:
Cureus, 13(5)
Van Oers, J, Krabbe, J, Kemna, E, Kluiters, Y, Vos, P, De Lange, D, Girbes, A & Beishuizen, A 2021, ' Mid-Regional Proadrenomedullin and Mid-Regional Proatrial Natriuretic Peptide Clearance Predicts Poor Outcomes Better Than Single Baseline Measurements in Critically Ill Patients With Pneumonia : A Retrospective Cohort Study ', Cureus, vol. 13, no. 5, pp. e15285 . https://doi.org/10.7759/cureus.15285
Cureus
Van Oers, J, Krabbe, J, Kemna, E, Kluiters, Y, Vos, P, De Lange, D, Girbes, A & Beishuizen, A 2021, ' Mid-Regional Proadrenomedullin and Mid-Regional Proatrial Natriuretic Peptide Clearance Predicts Poor Outcomes Better Than Single Baseline Measurements in Critically Ill Patients With Pneumonia : A Retrospective Cohort Study ', Cureus, vol. 13, no. 5, pp. e15285 . https://doi.org/10.7759/cureus.15285
Cureus
Background We assessed the ability of baseline and serial measurements of mid-regional proadrenomedullin (MR-proADM) and mid-regional proatrial natriuretic peptide (MR-proANP) to predict 28-day mortality in critically ill patients with pneumonia comp
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::bbb656125c6a4b5492774897de56fa1c
https://research.vumc.nl/en/publications/f735ffcf-1230-4299-8129-9a4329dff043
https://research.vumc.nl/en/publications/f735ffcf-1230-4299-8129-9a4329dff043
Autor:
Tim Hesselink, Georgios J. Vlachojannis, Antoinette Milané-Santman, Johannes G. Krabbe, Marcoen F. Scholten, Evelien W.M. Kemna, Mark W.M. Schellings, Florian Falter
Publikováno v:
The Journal of Applied Laboratory Medicine. 4:468-470
To the Editor: Activated clotting time (ACT) is used to monitor unfractionated heparin anticoagulation during invasive procedures such as percutaneous coronary or electrophysiology interventions. There are several point-of-care (POC) methods availabl
Autor:
Evelien W.M. Kemna, Florian Falter
Publikováno v:
Integrative Clinical Medicine. 3
Autor:
Agnes M.A. Oude Luttikhuis-Spanjer, Ron G.H. Speekenbrink, Renate Boudrie, Charline Kuipers, Johannes G. Krabbe, Reinhard Hoffman, Evelien W.M. Kemna, Stefan Majoor
Publikováno v:
Clinical Chemistry and Laboratory Medicine (CCLM). 55:e13-e16
Publikováno v:
Clinical chemistry and laboratory medicine. 55(11)
Autor:
Virág Krizsik, Balázs Sarkadi, Rita Padányi, Anita Schamberger, Katalin Német, László Homolya, Ágota Apáti, György Várady, Boglárka Erdélyi-Belle, Evelien W.M. Kemna, Tamás I. Orbán, Nóra Varga, Éva Karászi, Andrea Németh
Publikováno v:
Biochimica et Biophysica Acta (BBA) - Biomembranes. 1778:2700-2709
Expression of multidrug resistance ABC transporters has been suggested as a functional marker and chemoprotective element in early human progenitor cell types. In this study we examined the expression and function of the key multidrug-ABC transporter
Autor:
L. D. Dikkeschei, Pieter A. Jobse, Rob Fijnheer, Leo F. Verdonck, Johannes G. Krabbe, L.P.W.J. van den Heuvel, Evelien W.M. Kemna, Annuska L. M. Strunk, P. A. Kramer
Publikováno v:
International Journal of Hematology, 102, 477-481
International Journal of Hematology, 102, 4, pp. 477-481
International Journal of Hematology, 102, 4, pp. 477-481
Thrombotic thrombocytopenic purpura (TTP) is a life-threatening disease, characterized by microangiopathic hemolytic anaemia and thrombocytopenia, resulting in neurologic and/or renal abnormalities. We report a 49-year-old patient with a history of t